Holding(s) in Company
RNS Number : 1242U
Condor Gold PLC
13 January 2017
13 January 2017
Condor Gold plc
(''Condor'' or "the Company")
Holdings in Company
The Board of Condor announces that the Company has received the following TR-1 notification which is set out below. Accordingly Regent Pacific Group Limited ceases to hold any interests in the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
- Ends -
For further information please visit www.condorgold.com or contact:
| Condor Gold plc | Mark Child, Executive Chairman and CEO +44 (0) 20 7493 2734 |
| Beaumont Cornish Limited Numis Securities Limited | Roland Cornish and James Biddle +44 (0) 20 7628 3396 John Prior and James Black +44 (0) 20 72601000 |
| Farm Street Media | Simon Robinson +44 (0) 7593 340107 |
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:ii | Condor Gold plc | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | Yes | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | N/A | ||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | N/A | ||||
| An event changing the breakdown of voting rights | N/A | ||||
| Other (please specify): | N/A | ||||
| 3. Full name of person(s) subject to the notification obligation:iii | Regent Pacific Group Limited | ||||
| 4. Full name of shareholder(s)(if different from 3.):iv | Regent Pacific Group Limited | ||||
| 5. Date of the transaction and date on which the threshold is crossed or reached:v | 1,636,998 shares in CNR were disposed of to James Mellon (a Non-Executive Director of CNR) and his associate on 12 January 2017. | ||||
| 6. Date on which issuer notified: | 13 January 2017 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii | 3% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to sharesviii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| Ordinary shares | 1,636,998 | 1,636,998 | Nil | Nil | Nil | Nil | Nil | |||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| Nil | Nil | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | N/A | |
| 11. Number of voting rights proxy holder will cease to hold: | N/A | |
| 12. Date on which proxy holder will cease to hold voting rights: | N/A | |
13. Additional information: | N/A | |
| 14. Contact name: | Stella Fung | |
| 15. Contact telephone number: | +852 2514 6111 | |
Recent news on Regent Pacific
See all newsBrief: Regent Pacific Says SenstendTM Approved By NMPA For Premature Ejaculation In China
Brief: Regent Pacific Says Deep Longevity To Launch U.S. Expansion In Q1 2026
Brief: Regent Pacific Shall Allot And Issue 63.4 Million Shares At Hk$0.485 Per Share
Brief: Regent Pacific Announces Submission Of Senstend New Drug Application To NMPA In China
Brief: Regent Pacific Enters Manufacturing And Supply Agreement For SENSTEND